Genezen  

Stop by booth 641 to meet your next viral vector partner.

Founded in 2014, Genezen is a viral vector CDMO focused on supporting the demands of the cell and gene therapy manufacturing market worldwide — making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers the following capabilities, building on the company's expansive knowledge and experience. 

• Process Development
• Analytical Development
• cGMP Viral Vector Manufacturing
• Patient Sample Testing
• Cell Therapy Manufacturing
• Master Cell Bank Production and Expansion